U.S. FDA Approves New MENTOR ® MemoryGel BOOST™ Breast Implant
Irvine, Calif., (January 13, 2021) – Mentor Worldwide LLC, the number one global brand in breast aesthetics, and part of the Johnson & Johnson Medical Devices Companies** today announced that the U.S. Food and Drug Administration (FDA) approved the MENTOR® MemoryGel BOOST™ Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction. This product will be commercially available for surgeons in the United States in early 2022. Nearly 400,000 women undergo breast implant surgeries every year in the U.S.[1], and selecting an implant is a very persona...
Source: Johnson and Johnson - January 13, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
In Long COVID, CPET Finds Abnormalities Other Tests Don't In Long COVID, CPET Finds Abnormalities Other Tests Don't
Dysfunctional breathing, hypocapnia, and myalgic encephalomyelitis/chronic fatigue syndrome were seen in symptomatic patients post-acute COVID-19 despite normal chest imaging and pulmonary function.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 7, 2021 Category: Cardiology Tags: Cardiology News Source Type: news
Long-Haul COVID Can Include Chronic Fatigue
Nearly half of the post-COVID patients studied showed symptoms associated with chronic fatigue. (Source: WebMD Health)
Source: WebMD Health - November 30, 2021 Category: Consumer Health News Source Type: news
Covid long-haulers may experience abnormal breathing, chronic fatigue: Study
Many long-haul COVID-19 patients have chronic fatigue syndrome and other breathing issues months after their initial diagnosis, according to a study. Chronic fatigue syndrome is a medical condition that can often occur after a viral infection and cause fever, aching, and prolonged tiredness and depression. (Source: The Economic Times)
Source: The Economic Times - November 30, 2021 Category: Consumer Health News Source Type: news
'Long COVID' symptoms similar to chronic fatigue syndrome, study finds
People with " long-haul " COVID-19 have symptoms of chronic fatigue syndrome and other breathing problems months after first testing positive for the virus, a Journal of the American College of Cardiology study found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 29, 2021 Category: Consumer Health News Source Type: news
For patients with long COVID, chronic fatigue syndrome may offer a guiding star
Long COVID has been a reality since the beginning of the pandemic. The patients who have it are desperate for answers that doctors don't yet have.(Image credit: Helena Kubicka de Bragança) (Source: NPR Health and Science)
Source: NPR Health and Science - November 29, 2021 Category: Consumer Health News Authors: Mallory Yu Source Type: news
Please help out those with a disability or a chronic illness. You’ll also help yourself.
As my myalgic encephalomyelitis symptoms expand, my physical world shrinks. It’s often rough, but I’m fortunate in being a good Samaritan surrounded by fellow good Samaritans. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - November 14, 2021 Category: Consumer Health News Authors: Litsa Dremousis Source Type: news
UK launches trial of drug to tackle fatigue in long Covid patients
AXA1125 targets cell power plants that may be dysfunctional in long Covid patients with severe fatigueCoronavirus – latest updatesSee all our coronavirus coverageThe first trial of a drug to target the fatigue and muscle weakness experienced by more than half of people with long Covid has been launched in the UK. It is also the first drug trial in long Covid patients who were not hospitalised during their initial infection.The drug, called AXA1125, targets cellular power plants called mitochondria, which it is thought could be dysfunctional in the subset oflong Covid patients with severe fatigue. If successful, it could ...
Source: Guardian Unlimited Science - November 3, 2021 Category: Science Authors: Linda Geddes Science correspondent Tags: Long Covid Health Society Coronavirus Infectious diseases Medical research Science UK news ME / Chronic fatigue syndrome Source Type: news
New NICE guideline for diagnosis and management of myalgic encephalopathy/chronic fatigue syndrome
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2021 Category: Drugs & Pharmacology Source Type: news
Doctors told NOT to prescribe exercise to patients with chronic fatigue syndrome
New NHS guidelines for chronic fatigue syndrome sufferers have banned a controversial exercise regime that patient groups said made some people's illness worse, but Drs are worried about the change. (Source: the Mail online | Health)
Source: the Mail online | Health - October 29, 2021 Category: Consumer Health News Source Type: news
Reworked NICE advice on ME/CFS warns against 'one-size-fits-all' approach
Updated NICE guidance on ME/chronic fatigue syndrome highlights the need for personalised management plans for patients with the condition - acknowledging that there is no 'one-size-fits-all' approach for managing symptoms. (Source: GP Online News)
Source: GP Online News - October 29, 2021 Category: Primary Care Tags: Clinical News Source Type: news
Chronic fatigue syndrome advice scraps exercise therapy
The long-awaited advice makes it clear that exercise is not a panacea for the debilitating syndrome. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 29, 2021 Category: Consumer Health News Source Type: news
Chronic fatigue guidelines scrap exercise therapy advice
After delays, the advice is now out and makes it clear that exercise is not a panacea for the condition. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 28, 2021 Category: Consumer Health News Source Type: news
Flagship Pioneering spinout thinks it has a treatment for 'long Covid'
In a near-first for the biotech industry, Axcella Therapeutics Inc. is launching a clinical study investigating a new drug to treat "long Covid," a long-lasting version of the once-novel respiratory illness that is still little understood.
Axcella (Nasdaq: AXLA) is teaming up with Oxford University on a Phase 2 trial testing out a drug that targets the mitochondria, which is linked to chronic fatigue when dysregulated or damaged. Severe fatigue is one of the hallmark symptoms of long Covid and one… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 26, 2021 Category: American Health Authors: Rowan Walrath Source Type: news
NICE publication of its guideline on ME/CFS
NICE has announced the next steps for publication of its updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS). (Source: NHS Networks)
Source: NHS Networks - October 21, 2021 Category: UK Health Source Type: news
